Mild infantile hypercalcemia: diagnostic tests and outcomes

Infantile hypercalcemia remains poorly understood in many cases. Prior research has shown that diagnosing this condition often involves standard tests of calcium and phosphate metabolism. However, the diagnostic yield remains limited in a significant proportion of cases. No prior work had resolved the long-term outcomes of affected infants. This gap motivated researchers to investigate additional diagnostic tools and clinical outcomes in a cohort followed over three years. It was already known that hypercalcemia can lead to complications such as nephrocalcinosis. But the extent of diagnostic uncertainty and the role of newer tests like calcium-sensing receptor gene analysis had not been fully explored. This study aimed to address these uncertainties by expanding the diagnostic panel and tracking outcomes over time. The findings may help refine diagnostic approaches and improve patient management in this rare condition.

The aim of this study was to evaluate the outcomes of infants diagnosed with hypercalcemia over a three-year period. Researchers sought to determine the proportion of cases with identifiable causes versus those remaining unexplained. They also aimed to assess the diagnostic value of adding 1,25(OH)2D and calcium-sensing receptor gene analysis to standard tests. The motivation stemmed from the high rate of undiagnosed cases in prior studies. This paper focuses on whether expanded testing improves diagnostic yield and informs clinical management. Researchers also wanted to track whether hypercalcemia resolved or persisted in affected infants. The study sought to clarify the long-term prognosis and identify factors associated with persistent disease. These goals were driven by the need to improve diagnostic accuracy and patient follow-up in this rare condition.

The study involved 32 infants presenting with hypercalcemia between July 2002 and September 2008. Researchers collected data on calcium and phosphate metabolism, along with additional tests including serum insulin-like growth factor-1 and calcitonin. Urine citrate levels were also measured. Genetic analysis of the calcium-sensing receptor gene was performed in all cases. Standard diagnostic tests were supplemented with 1,25(OH)2D measurements. Researchers categorized patients based on the presence of identifiable causes or probable causes. They tracked outcomes such as resolution of hypercalcemia and persistence of nephrocalcinosis. The study design allowed for a comprehensive assessment of both biochemical and clinical features.

Out of 32 patients, 14% had a recognized cause and 14% had a probable cause for hypercalcemia. Eleven patients with nephrocalcinosis had lower mean weight SDS and higher calcium levels. The addition of 1,25(OH)2D and calcium-sensing receptor gene analysis improved diagnostic yield. In 20 patients, hypercalcemia resolved over time. However, in approximately one-third of cases, hypercalcemia, hypercalciuria, or nephrocalcinosis persisted. Patients with nephrocalcinosis showed significantly lower weight SDS compared to others. Nonsuppressed parathyroid hormone levels were observed in cases without a clear cause. These findings suggest that expanded testing may aid in diagnosing a subset of previously unexplained cases.

The authors concluded that clinical outcomes for infants with hypercalcemia are generally favorable. However, approximately one-third of patients require ongoing follow-up due to persistent symptoms. The addition of 1,25(OH)2D and calcium-sensing receptor gene analysis to standard tests may improve diagnostic yield. These findings suggest that expanded testing can help identify more cases with probable causes. The presence of nephrocalcinosis was associated with lower weight SDS and higher calcium levels. The study highlights the importance of comprehensive diagnostic panels in managing infantile hypercalcemia. Researchers propose that these findings may inform future diagnostic approaches. The authors emphasize the need for long-term monitoring in a subset of patients.